CD24 has been identified as a biomarker for neural lineage differentiation of human stem cells [36] and been shown to directly affect the risk and progression of hepatitis B virus, demonstrating increased risk of more rapid progression to liver cirrhosis and hepatocellular carcinoma [37]. This evidence concerns the gene CD24 and hepatocellular carcinoma.